Ethyl Acetate

Ethyl Acetate

SCHEMBL11045341

CCC(=O)O.CCOC(C)=O

nearest known ligand 0.78

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 10/20 0.78
LMNA P02545 1/20 0.78
HSD17B10 Q99714 1/20 0.78
FFAR3 O14843 1/20 0.56
SOAT1 P35610 1/20 0.50
TSHR P16473 2/20 0.48
ALOX15 P16050 1/20 0.43
MGAM O43451 1/20 0.43
GAA P10253 1/20 0.43
SI P14410 1/20 0.43
MGAM2 Q2M2H8 1/20 0.43
CYP2D6 P10635 2/20 0.41
EGLN1 Q9GZT9 1/20 0.41
HCAR2 Q8TDS4 1/20 0.41
TDP1 Q9NUW8 1/20 0.40
TRPA1 O75762 1/20 0.40
GLO1 Q04760 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
CA12 O43570 1/20 0.38
CA1 P00915 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Ethyl Acetate SCHEMBL27986340 0.97 ALDH1A1 (0.74) ALDH1A1LMNAHSD17B10FFAR3SOAT1
Ethyl Acetate SCHEMBL18921563 0.91
Ethyl Acetate SCHEMBL3525677 0.88 ALDH1A1 (0.88) ALDH1A1LMNAHSD17B10FFAR3SOAT1
Ethyl Acetate SCHEMBL10598534 0.88 ALDH1A1 (0.88) ALDH1A1LMNAHSD17B10FFAR3SOAT1
Ethyl Acetate SCHEMBL28294067 0.88 ALDH1A1 (0.88) ALDH1A1LMNAHSD17B10SOAT1TSHR
Ethyl Acetate SCHEMBL1526797 0.88 ALDH1A1 (0.88) ALDH1A1LMNAHSD17B10FFAR3SOAT1
Ethyl Acetate SCHEMBL15065336 0.88 ALDH1A1 (0.88) ALDH1A1LMNAHSD17B10FFAR3SOAT1
Ethyl Acetate SCHEMBL282517 0.88 ALDH1A1 (0.88) ALDH1A1LMNAHSD17B10FFAR3SOAT1
Ethyl Acetate SCHEMBL11286195 0.88 ALDH1A1 (0.88) ALDH1A1LMNAHSD17B10FFAR3SOAT1
Ethyl Acetate SCHEMBL5937435 0.88 ALDH1A1 (0.88) ALDH1A1LMNAHSD17B10SOAT1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4439346-A THERMOCHROMIC ALLIED CORPORATION (US) 1984-03-27 US claimed
CN-119786733-A Electrolyte and battery adapting to lithium manganese iron phosphate positive electrode material 湖北亿纬动力有限公司 2025-04-08 CN disclosed
US-12171835-B2 Furan-aspidospermine dimer or pharmaceutically acceptable salt thereof, and preparation method, use and pharmaceutical composition kunming institute of botany (CN) 2024-12-24 US disclosed
CN-113068089-B Vibration generating device 乐金显示有限公司 2024-07-02 CN disclosed
CN-115073481-B Furana quebracho base dimer or pharmaceutically acceptable salt thereof, and preparation method and application thereof, and pharmaceutical composition 中国科学院昆明植物研究所 2024-04-12 CN disclosed
CN-110256378-B Preparation method of cellulose aviation oil intermediate 中国科学院广州能源研究所 2023-07-25 CN disclosed
CN-115160186-B Phenyl carbamate crystal form and preparation method thereof 比皮艾思药物研发有限公司 2023-03-07 CN disclosed
CN-115160186-A Phenyl carbamate crystal form and preparation method thereof 比皮艾思药物研发有限公司 2022-10-11 CN disclosed
US-20220296724-A1 Furan-Aspidospermine Dimer or Pharmaceutically Acceptable Salt Thereof, and Preparation Method, Use and Pharmaceutical Composition KUNMING INSTITUTE OF BOTANY, CHINESE ACADEMY OF SCIENCES (CN) 2022-09-22 US disclosed
CN-115073481-A Furan quebrachitol dimer or pharmaceutically acceptable salt thereof, preparation method and application thereof, and pharmaceutical composition 中国科学院昆明植物研究所 2022-09-20 CN disclosed
CN-210045034-U Utilize active carbon to carry out exhaust treatment device 成都华高生物制品有限公司 2020-02-11 CN disclosed
US-20190284501-A1 LUBRICATING OIL COMPOSITION CONTAINING AN ANTIFOAMING AGENT EXXONMOBIL RESEARCH AND ENGINEERING COMPANY 2019-09-19 US disclosed
EP-3460029-A1 LUBRICATING OIL COMPOSITION CONTAINING AN ANTIFOAMING AGENT ExxonMobil Research and Engineering Company (US) 2019-03-27 EP disclosed
CN-102579503-A Method for separating skin of eupolyphaga egg clamp from egg inside eupolyphaga egg clamp UNIV SHANDONG NORMAL 2012-07-18 CN disclosed
CN-101282725-A Therapeutic agent for diabetes TAKEDA CHEMICAL INDUSTRIES LTD (JP) 2008-10-08 CN disclosed
CN-1031289-C Production method and relevant glue for the asymmetrical gas separating membrance with gradient density surface layer POMARE LTD (US) 1996-03-13 CN disclosed
CN-1009430-B ASYMMETRIC GAS SEPN. MEMBRANE COMPRISING AROMATIC POLYSULPHONE PERMEA INC (US) 1990-09-05 CN disclosed
CN-87106270-A Process and sizing for producing asymmetric gas separation membranes with graded density skins 1988-04-27 CN disclosed
CN-87106272-A Asymmetric gas separation membrane with rung-density cortical 1988-03-02 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12171835-B2 Furan-aspidospermine dimer or pharmaceutically acceptable salt thereof, and preparation method, use and pharmaceutical composition TSLP, PTMS, TYMS ALDH1A1 2484/4885LMNA 4529/4885HSD17B10 1737/4885
US-20220296724-A1 Furan-Aspidospermine Dimer or Pharmaceutically Acceptable Salt Thereof, and Preparation Method, Use and Pharmaceutical Composition TSLP, PTMS, TYMS ALDH1A1 2484/4885LMNA 4529/4885HSD17B10 1737/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.